These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 20566767)

  • 41. Factors influencing susceptibility of Nocardia species to trimethoprim-sulfamethoxazole.
    Bennett JE; Jennings AE
    Antimicrob Agents Chemother; 1978 Apr; 13(4):624-7. PubMed ID: 352260
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Emergence of sulfamethoxazole-trimethoprim resistant Shigella flexneri in Northeastern Brazil.
    Tiemens KM; Shipley PL; Correia RA; Shields DS; Guerrant RL
    Arq Gastroenterol; 1985; 22(4):162-5. PubMed ID: 3915680
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Comparison of the in vitro antibacterial activity of trimethoprim-sulfadiazine and trimethoprim-sulfamethoxazole combinations].
    Thabaut A
    Therapie; 1983; 38(4):399-404. PubMed ID: 6606237
    [No Abstract]   [Full Text] [Related]  

  • 44. Dosing regimens of cotrimoxazole (trimethoprim-sulfamethoxazole) for melioidosis.
    Cheng AC; McBryde ES; Wuthiekanun V; Chierakul W; Amornchai P; Day NP; White NJ; Peacock SJ
    Antimicrob Agents Chemother; 2009 Oct; 53(10):4193-9. PubMed ID: 19620336
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In vitro activities of trimethoprim and sulfamethoxazole against Listeria monocytogenes.
    Winslow DL; Pankey GA
    Antimicrob Agents Chemother; 1982 Jul; 22(1):51-4. PubMed ID: 6812496
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Co-trimoxazole susceptibility tests improved with separate trimethoprim and sulfamethoxazole disks.
    Amyes SG
    J Clin Microbiol; 1981 Apr; 13(4):613-7. PubMed ID: 7014612
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A comparison of the in vitro activities of sulfamethoxazole and sulfadiazine combinations with trimethoprim.
    Kuipers JS
    Chemotherapy; 1979; 25(2):77-82. PubMed ID: 446188
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Response of yeast and mycelial phases of Histoplasma capsulatum to amphotericin B and actinomycin D.
    Cheung SC; Medoff G; Schlessinger D; Kobayashi GS
    Antimicrob Agents Chemother; 1975 Oct; 8(4):498-503. PubMed ID: 1190756
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Agar dilution susceptibility of Bacteroides spp. to sulfamethoxazole and trimethoprim: correlation with a disk diffusion technique.
    Riley TV
    Antimicrob Agents Chemother; 1981 Dec; 20(6):731-5. PubMed ID: 7325639
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The susceptibility of Serratia marcescens to sulfamethoxazole, trimethoprim, and trimethoprim-sulfamethoxazole.
    Adeniyi-Jones C; Neilly S; Roberts RS; Kaufmann NR
    J Infect Dis; 1973 Nov; 128():Suppl:534-42 p. PubMed ID: 4585956
    [No Abstract]   [Full Text] [Related]  

  • 51. Susceptibility of Branhamella catarrhalis to sulphamethoxazole and trimethoprim.
    Riley TV; Digiovanni C; Hoyne GF
    J Antimicrob Chemother; 1987 Jan; 19(1):39-43. PubMed ID: 3494008
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Activity of the trimethoprim-sulfamethoxazole association in experimental toxoplasmosis in mice. Histochemical study].
    Cellesi C; Barberi A; Terragna A
    Boll Ist Sieroter Milan; 1973; 52(1):70-6. PubMed ID: 4714452
    [No Abstract]   [Full Text] [Related]  

  • 53. Combined action of sulphamethoxazole and trimethoprim against clinically-isolated sulphonamide-resistant bacteria.
    Grey D; Hamilton-Miller JM; Brumfitt W
    Chemotherapy; 1979; 25(5):296-302. PubMed ID: 383418
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Activity of the trimethoprim-sulfamethoxazole association in experimental toxoplasmosis in mice. Histological and immuno-histological study].
    Terragna A; Cellesi C; Barberi A
    Boll Ist Sieroter Milan; 1973; 52(1):60-9. PubMed ID: 4576904
    [No Abstract]   [Full Text] [Related]  

  • 55. Spurious sulfamethoxazole-trimethoprim resistance of Salmonella typhi.
    Escamilla J; Kilpatrick ME; Ugarte HF
    J Clin Microbiol; 1986 Jan; 23(1):205-6. PubMed ID: 3486190
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Activity of sulfamethoxazole trimethoprim against Bacteroides fragilis.
    Nadaud M
    Zentralbl Bakteriol Orig A; 1978 Nov; 242(1):79-84. PubMed ID: 735555
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In vitro susceptibilities of oxacillin-resistant Staphylococcus aureus to dapsone and sulfamethoxazole alone and in combination with trimethoprim.
    Lambertus MW; Kwok RY; Mulligan ME
    Antimicrob Agents Chemother; 1990 Jul; 34(7):1453-5. PubMed ID: 2117420
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In-vitro sensitivity of Bordetella pertussis.
    Zackrisson G; Brorson JE; Krantz I; Trollfors B
    J Antimicrob Chemother; 1983 May; 11(5):407-11. PubMed ID: 6307963
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Susceptibility of Mycobacterium tuberculosis to sulfamethoxazole, trimethoprim and their combination over a 12 year period in Taiwan.
    Huang TS; Kunin CM; Yan BS; Chen YS; Lee SS; Syu W
    J Antimicrob Chemother; 2012 Mar; 67(3):633-7. PubMed ID: 22127584
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In vitro susceptibility of some porcine respiratory tract pathogens to aditoprim, trimethoprim, sulfadimethoxine, sulfamethoxazole, and combinations of these agents.
    Mengelers MJ; van Klingeren B; van Miert AS
    Am J Vet Res; 1990 Nov; 51(11):1860-4. PubMed ID: 2240813
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.